The expansion of targetable biomarkers for CAR T cell therapy.

Townsend, Michelle H; Shrestha, Gajendra; Robison, Richard A; O'Neill, Kim L

Townsend, Michelle H; Shrestha, Gajendra; Robison, Richard A; O'Neill, Kim L.

Afiliação

Townsend MH; Department of Microbiology and Molecular Biology, Brigham Young University, 3142 LSB, Provo, UT, 84602, USA.
Shrestha G; Department of Microbiology and Molecular Biology, Brigham Young University, 3142 LSB, Provo, UT, 84602, USA.
Robison RA; Thunder Biotech, Highland, UT, USA.
O'Neill KL; Department of Microbiology and Molecular Biology, Brigham Young University, 3142 LSB, Provo, UT, 84602, USA.

J Exp Clin Cancer Res ; 37(1): 163, 2018 Jul 21.

Article em En | MEDLINE | ID: mdl-30031396

Assuntos

Biomarcadores/química; Imunoterapia Adotiva/métodos; Linfócitos T Citotóxicos/metabolismo; Humanos

Palavras-chave

Biomarkers; CAR T cell therapy; Combination therapy; Hematological malignancies; Solid tumors; Targets; Tumor associated antigens (TAA); Tumor specific antigens (TSA)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Biomarcadores / Imunoterapia Adotiva Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google